{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:46:06Z","timestamp":1760298366358},"reference-count":124,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.ejim.2011.04.009","type":"journal-article","created":{"date-parts":[[2011,6,9]],"date-time":"2011-06-09T01:15:55Z","timestamp":1307582155000},"page":"561-568","source":"Crossref","is-referenced-by-count":18,"title":["Clinical approach to severe Clostridium difficile infection: Update for the hospital practitioner"],"prefix":"10.1016","volume":"22","author":[{"given":"Chaitanya","family":"Pant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas J.","family":"Sferra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Minocha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2011.04.009_bb0005","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1093\/clinids\/12.Supplement_1.S41","article-title":"Diarrhea in developed and developing countries: magnitude, special settings, and etiologies","volume":"12","author":"Guerrant","year":"1990","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0196-6553(95)90060-8","article-title":"Epidemiology of infectious and iatrogenic nosocomial diarrhea in a cohort of general medicine patients","volume":"23","author":"McFarland","year":"1995","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ejim.2011.04.009_bb0015","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/SMJ.0b013e3181eab419","article-title":"Clostridium difficile: an update for the primary care clinician","volume":"103","author":"Salkind","year":"2010","journal-title":"South Med J"},{"key":"10.1016\/j.ejim.2011.04.009_bb0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/MAJ.0b013e3181e939d8","article-title":"Clostridium difficile infection","volume":"340","author":"Heinlen","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ejim.2011.04.009_bb0025","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s10151-010-0574-3","article-title":"Review of medical and surgical management of Clostridium difficile infection","volume":"14","author":"Faris","year":"2010","journal-title":"Tech Coloproctol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0030","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1086\/521854","article-title":"Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents","volume":"45","author":"Riggs","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0035","series-title":"Clostridium difficile infection: how to deal with the problem. A board to ward approach","year":"2008"},{"key":"10.1016\/j.ejim.2011.04.009_bb0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.269.1.71","article-title":"Diagnosis and treatment of Clostridium difficile colitis","volume":"269","author":"Fekety","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2011.04.009_bb0045","doi-asserted-by":"crossref","first-page":"b1563","DOI":"10.1136\/bmj.b1563","article-title":"The role of surgery in Clostridium difficile colitis","volume":"338","author":"Noblett","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2011.04.009_bb0050","article-title":"Update on Clostridium difficile infection","author":"O'Donoghue","year":"2010","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0055","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.surg.2007.12.008","article-title":"Risk factors for the development of fulminant Clostridium difficile colitis","volume":"143","author":"Greenstein","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/j.ejim.2011.04.009_bb0060","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1001\/archinte.162.19.2177","article-title":"The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea","volume":"162","author":"Hurley","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0065","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1001\/archsurg.2009.51","article-title":"Fulminant Clostridium difficile colitis: patterns of care and predictors of mortality","volume":"144","author":"Sailhamer","year":"2009","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejim.2011.04.009_bb0070","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1503\/cmaj.1041104","article-title":"Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity","author":"Pepin","year":"2004","journal-title":"CMAJ"},{"key":"10.1016\/j.ejim.2011.04.009_bb0075","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa051639","article-title":"A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality","volume":"353","author":"Loo","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0080","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa051590","article-title":"An epidemic, toxin gene-variant strain of Clostridium difficile","volume":"353","author":"McDonald","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0085","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(05)67420-X","article-title":"Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe","volume":"366","author":"Warny","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2011.04.009_bb0090","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1128\/AAC.00146-08","article-title":"Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI\/NAP1\/027 strain","volume":"52","author":"Labbe","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ejim.2011.04.009_bb0095","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1086\/520984","article-title":"Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027\/toxinotype III in The Netherlands","volume":"45","author":"Goorhuis","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1086\/510391","article-title":"A portrait of the geographic dissemination of the Clostridium difficile North American pulsed-field type 1 strain and the epidemiology of C. difficile-associated disease in Quebec","volume":"44","author":"Hubert","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0105","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jhin.2009.02.020","article-title":"Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors","volume":"72","author":"Sundram","year":"2009","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ejim.2011.04.009_bb0110","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ijantimicag.2009.04.004","article-title":"Clostridium difficile ribotype 027 arrives in Hong Kong","volume":"34","author":"Cheng","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ejim.2011.04.009_bb0115","article-title":"First isolation of Clostridium difficile 027 in Japan","volume":"12","author":"Kato","year":"2007","journal-title":"Euro Surveill"},{"key":"10.1016\/j.ejim.2011.04.009_bb0120","doi-asserted-by":"crossref","first-page":"520","DOI":"10.3346\/jkms.2009.24.3.520","article-title":"The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea","volume":"4","author":"Tae","year":"2009","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.ejim.2011.04.009_bb0125","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1086\/592257","article-title":"Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078","volume":"47","author":"Goorhuis","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2036.2006.02707.x","article-title":"Review article: proton pump inhibitors and bacterial overgrowth","volume":"23","author":"Williams","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2011.04.009_bb0135","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1111\/j.1572-0241.2007.01275.x","article-title":"Systematic review of the risk of enteric infection in patients taking acid suppression","volume":"102","author":"Leonard","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0140","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1086\/502023","article-title":"Canadian Nosocomial Infection Surveillance P. Morbidity, mortality, and healthcare burden of nosocomial Clostridium difficile-associated diarrhea in Canadian hospitals","volume":"23","author":"Miller","year":"2002","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3201\/eid1205.051064","article-title":"Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996\u20132003","volume":"12","author":"McDonald","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0150","first-page":"361","article-title":"Increase in deaths related to enterocolitis due to Clostridium difficile in the United States, 1999\u20132002","volume":"121","author":"Wysowski","year":"2006","journal-title":"Public Health Rep"},{"key":"10.1016\/j.ejim.2011.04.009_bb0155","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1086\/522187","article-title":"Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system","volume":"45","author":"McFarland","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0160","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3201\/eid1406.071447","article-title":"Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000\u20132005","volume":"14","author":"Zilberberg","year":"2008","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0165","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1086\/338260","article-title":"Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile","volume":"34","author":"Kyne","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0170","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1086\/522676","article-title":"The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences","volume":"28","author":"O'Brien","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0175","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/MOG.0b013e32831da7c4","article-title":"Renewed interest in a difficult disease: Clostridium difficile infections\u2014epidemiology and current treatment strategies","volume":"25","author":"McFarland","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0180","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1099\/jmm.0.47742-0","article-title":"Processing of Clostridium difficile toxins","volume":"57","author":"Giesemann","year":"2008","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0185","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/nrgastro.2010.190","article-title":"Clostridium difficile infection: epidemiology, risk factors and management","volume":"8","author":"Ananthakrishnan","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0190","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/pgmj.2004.028480","article-title":"Pathogenesis and treatment of Clostridium difficile infection","volume":"81","author":"Tonna","year":"2005","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.ejim.2011.04.009_bb0195","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.3748\/wjg.15.1554","article-title":"Clostridium difficile associated infection, diarrhea and colitis","volume":"15","author":"Hookman","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0200","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2009.02.073","article-title":"Clostridium difficile infection caused by the epidemic BI\/NAP1\/027 strain","volume":"136","author":"O'Connor","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.04.009_bb0205","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1185\/030079908X253735","article-title":"Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence","volume":"24","author":"Deshpande","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.ejim.2011.04.009_bb0210","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1097\/MPG.0b013e3181a118c6","article-title":"Clostridium difficile infections: emerging epidemiology and new treatments","volume":"48","author":"Cohen","year":"2009","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ejim.2011.04.009_bb0215","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1155\/2003\/723471","article-title":"Clostridium difficile-associated diarrhea: predictors of severity in patients presenting to the emergency department","volume":"17","author":"Andrews","year":"2003","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0225","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.3748\/wjg.14.4338","article-title":"Univariate and multivariate analysis of risk factors for severe Clostridium difficile-associated diarrhoea: importance of co-morbidity and serum C-reactive protein","volume":"14","author":"Hardt","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0230","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.sla.0000236628.79550.e5","article-title":"Impact of emergency colectomy on survival of patients with fulminant Clostridium difficile colitis during an epidemic caused by a hypervirulent strain","volume":"245","author":"Lamontagne","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejim.2011.04.009_bb0235","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1007\/DCR.0b013e31819a69aa","article-title":"Risk factors for mortality following emergency colectomy for fulminant Clostridium difficile infection","volume":"52","author":"Pepin","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejim.2011.04.009_bb0240","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1365-2036.2008.03914.x","article-title":"Predictors of serious complications due to Clostridium difficile infection","volume":"29","author":"Gujja","year":"2009","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ejim.2011.04.009_bb0245","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3201\/eid1503.080312","article-title":"Clinical risk factors for severe Clostridium difficile-associated disease","volume":"15","author":"Henrich","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0250","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1463-1318.2006.01013.x","article-title":"Risk factors for severity and relapse of pseudomembranous colitis in an elderly population","volume":"9","author":"Moshkowitz","year":"2007","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0255","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1086\/496986","article-title":"Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec","volume":"41","author":"Pepin","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0260","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2310\/JIM.0b013e3181d5d9e0","article-title":"Optimum timing of blood tests for monitoring patients with Clostridium difficile-associated diarrhea","volume":"58","author":"Bhangu","year":"2010","journal-title":"J Investig Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0265","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2310\/JIM.0b013e3181d5d9e0","article-title":"Letter in Response to the Article \u201cOptimum Timing of Blood Tests for Monitoring Patients with Clostridium difficile-Associated Diarrhea\u201d","volume":"58","author":"Pant","year":"2010","journal-title":"J Investig Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0270","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/MOT.0b013e3283186b51","article-title":"Clostridium difficile infection in solid organ transplant recipients","volume":"13","author":"Riddle","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.ejim.2011.04.009_bb0275","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/jhin.2002.1356","article-title":"Outbreak of Clostridium difficile-related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics","volume":"53","author":"Blot","year":"2003","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ejim.2011.04.009_bb0280","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1093\/ndt\/gfh428","article-title":"Clostridium difficile diarrhoea in the immunosuppressed patient\u2014update on prevention and management","volume":"19","author":"Schaier","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejim.2011.04.009_bb0285","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1111\/j.1600-6143.2009.02891.x","article-title":"Clostridium difficile in solid organ transplant recipients","volume":"9","author":"Dubberke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ejim.2011.04.009_bb0290","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1399-0012.2009.01035.x","article-title":"Clostridium difficile-associated disease in allogeneic hematopoietic stem-cell transplant recipients: risk associations, protective associations, and outcomes","volume":"24","author":"Dubberke","year":"2010","journal-title":"Clin Transplant"},{"key":"10.1016\/j.ejim.2011.04.009_bb0295","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.gtc.2009.07.003","article-title":"Clostridium difficile and inflammatory bowel disease","volume":"38","author":"Ananthakrishnan","year":"2009","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.ejim.2011.04.009_bb0300","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1136\/gut.2007.128231","article-title":"Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease","volume":"57","author":"Ananthakrishnan","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.ejim.2011.04.009_bb0305","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.cgh.2009.05.031","article-title":"Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection","volume":"7","author":"Ben-Horin","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0310","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0272-5231(05)70030-7","article-title":"Gastrointestinal problems in the chronically critically ill patient","volume":"22","author":"Sheth","year":"2001","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0315","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2008.02198.x","article-title":"Clinical review of the management of fulminant Clostridium difficile infection","volume":"103","author":"Jaber","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0320","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s11894-002-0077-0","article-title":"Clostridium difficile-associated diarrhea: current strategies for diagnosis and therapy","volume":"4","author":"Moyenuddin","year":"2002","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.ejim.2011.04.009_bb0325","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1469-0691.2009.03098.x","article-title":"European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI)","volume":"15","author":"Crobach","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ejim.2011.04.009_bb0330","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1128\/JCM.01082-09","article-title":"Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods","volume":"47","author":"Eastwood","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0335","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0009-9260(05)81744-1","article-title":"Pseudomembranous colitis: diagnostic sensitivity of the abdominal plain radiograph","volume":"49","author":"Boland","year":"1994","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0340","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.2214\/AJR.04.1697","article-title":"Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings","volume":"186","author":"Ash","year":"2006","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0345","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2214\/ajr.176.3.1760635","article-title":"Evaluating the CT diagnosis of Clostridium difficile colitis: should CT guide therapy?","volume":"176","author":"Kirkpatrick","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0350","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0016-5085(19)33962-9","article-title":"An experience of ulcerative colitis. I. Toxic dilation in 55 cases","volume":"57","author":"Jalan","year":"1969","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.04.009_bb0355","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4253\/wjge.v2.i8.293","article-title":"Toxic megacolon associated Clostridium difficile colitis","volume":"2","author":"Sayedy","year":"2010","journal-title":"World J Gastrointest Endosc"},{"key":"10.1016\/j.ejim.2011.04.009_bb0360","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cgh.2006.12.028","article-title":"Impact of Clostridium difficile on inflammatory bowel disease","volume":"5","author":"Issa","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0365","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/00365520802321238","article-title":"Absence of pseudomembranes in Clostridium difficile-associated diarrhea in patients using immunosuppression agents","volume":"44","author":"Nomura","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0370","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/archinte.161.4.525","article-title":"Clostridium difficile\u2014associated diarrhea: a review","volume":"161","author":"Mylonakis","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0375","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1056\/NEJMra0707500","article-title":"Clostridium difficile\u2014more difficult than ever","volume":"359","author":"Kelly","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0380","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0385","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1086\/596711","article-title":"Antimotility agents for the treatment of Clostridium difficile diarrhea and colitis","volume":"48","author":"Koo","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0390","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1086\/587654","article-title":"The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection","volume":"46","author":"Bartlett","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0395","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1128\/JCM.02437-07","article-title":"Characterization of Clostridium difficile strains isolated from patients in Ontario, Canada, from 2004 to 2006","volume":"46","author":"Martin","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0400","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1086\/506349","article-title":"Tolevamer, a novel nonantibiotic polymer, compared with vancomycin in the treatment of mild to moderately severe Clostridium difficile-associated diarrhea","volume":"43","author":"Louie","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0405","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1086\/519265","article-title":"A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity","volume":"45","author":"Zar","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0410","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1086\/587656","article-title":"Vancomycin for the treatment of Clostridium difficile infection: for whom is this expensive bullet really magic?","volume":"46","author":"Pepin","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0415","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1056\/NEJMcp011603","article-title":"Clinical practice. Antibiotic-associated diarrhea","volume":"346","author":"Bartlett","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0420","first-page":"867","article-title":"Approach to patients with multiple relapses of antibiotic-associated pseudomembranous colitis","volume":"80","author":"Tedesco","year":"1985","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0425","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/342334","article-title":"Adjunctive intracolonic vancomycin for severe Clostridium difficile colitis: case series and review of the literature","volume":"35","author":"Apisarnthanarak","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0430","first-page":"1357","article-title":"Rectal use of vancomycin","volume":"28","author":"Bublin","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ejim.2011.04.009_bb0435","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJM199308193290819","article-title":"Intracolonic vancomycin for pseudomembranous colitis","volume":"329","author":"Pasic","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0440","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11908-009-0004-8","article-title":"New antimicrobial agents for patients with Clostridium difficile infections","volume":"11","author":"Bartlett","year":"2009","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.ejim.2011.04.009_bb0445","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s10156-002-0215-5","article-title":"Sudden increase of vancomycin-resistant enterococcal infections in a Korean tertiary care hospital: possible consequences of increased use of oral vancomycin","volume":"9","author":"Shin","year":"2003","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ejim.2011.04.009_bb0450","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004610.pub3","article-title":"Antibiotic treatment for Clostridium difficile-associated diarrhea in adults","volume":"3","author":"Nelson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2011.04.009_bb0455","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1086\/599224","article-title":"Intravenous tigecycline as adjunctive or alternative therapy for severe refractory Clostridium difficile infection","volume":"48","author":"Herpers","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0460","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1517\/14656566.2010.485614","article-title":"Fidaxomicin (OPT-80) for the treatment of Clostridium difficile infection","volume":"11","author":"Miller","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ejim.2011.04.009_bb0465","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0470","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004611.pub2","article-title":"Probiotics for treatment of Clostridium difficile-associated colitis in adults","volume":"1","author":"Pillai","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ejim.2011.04.009_bb0475","doi-asserted-by":"crossref","first-page":"949","DOI":"10.2147\/TCRM.S3145","article-title":"New advances in the treatment of Clostridium difficile infection (CDI)","volume":"4","author":"Hedge","year":"2008","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.ejim.2011.04.009_bb0480","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1128\/AAC.01085-08","article-title":"Tolevamer is not efficacious in the neutralization of cytotoxin in a human gut model of Clostridium difficile infection","volume":"53","author":"Baines","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ejim.2011.04.009_bb0485","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2146\/ajhp090168","article-title":"Probiotics","volume":"67","author":"Williams","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.ejim.2011.04.009_bb0490","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.anaerobe.2009.09.002","article-title":"Evidence-based review of probiotics for antibiotic-associated diarrhea and Clostridium difficile infections","volume":"15","author":"McFarland","year":"2009","journal-title":"Anaerobe"},{"key":"10.1016\/j.ejim.2011.04.009_bb0495","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/IAI.67.1.302-307.1999","article-title":"Saccharomyces boulardii protease inhibits the effects of Clostridium difficile toxins A and B in human colonic mucosa","volume":"67","author":"Castagliuolo","year":"1999","journal-title":"Infect Immun"},{"key":"10.1016\/j.ejim.2011.04.009_bb0500","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1503\/cmaj.050350","article-title":"Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review","volume":"173","author":"Dendukuri","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/j.ejim.2011.04.009_bb0505","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s12098-008-0119-1","article-title":"Probiotic use in the critically ill","volume":"75","author":"Singhi","year":"2008","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.ejim.2011.04.009_bb0510","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/QCO.0b013e32833229ce","article-title":"Clostridium difficile: controversies and approaches to management","volume":"22","author":"Bauer","year":"2009","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0515","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1002\/jhm.542","article-title":"Intravenous immunoglobulin for the treatment of severe Clostridium difficile colitis: an observational study and review of the literature","volume":"5","author":"Abougergi","year":"2010","journal-title":"J Hosp Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0520","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.ijid.2008.11.012","article-title":"The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review","volume":"13","author":"O'Horo","year":"2009","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0525","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1056\/NEJMoa0907635","article-title":"Treatment with monoclonal antibodies against Clostridium difficile toxins","volume":"362","author":"Lowy","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0530","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.anaerobe.2009.09.007","article-title":"Fecal bacteriotherapy for recurrent Clostridium difficile infection","volume":"15","author":"Bakken","year":"2009","journal-title":"Anaerobe"},{"key":"10.1016\/j.ejim.2011.04.009_bb0535","doi-asserted-by":"crossref","DOI":"10.1097\/MCG.0b013e3181dac035","article-title":"Treatment of Refractory\/Recurrent C. difficile-associated Disease by Donated Stool Transplanted Via Colonoscopy: A Case Series of 12 Patients","author":"Yoon","year":"2010","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0540","first-page":"3028","article-title":"\u201cFlora Power\u201d\u2014fecal bacteria cure chronic C. difficile diarrhea","volume":"95","author":"Borody","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0545","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/00365529850171666","article-title":"Faecal short-chain fatty acids in patients with antibiotic-associated diarrhoea, before and after faecal enema treatment","volume":"33","author":"Gustafsson","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ejim.2011.04.009_bb0550","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-148-8-200804150-00024","article-title":"Successful treatment of fulminant Clostridium difficile infection with fecal bacteriotherapy","volume":"148","author":"You","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2011.04.009_bb0555","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1046\/j.1365-2168.1998.00519.x","article-title":"Timing of surgery for fulminating pseudomembranous colitis","volume":"85","author":"Synnott","year":"1998","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejim.2011.04.009_bb0560","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/000313480807400105","article-title":"Early surgical intervention for fulminant pseudomembranous colitis","volume":"74","author":"Ali","year":"2008","journal-title":"Am Surg"},{"key":"10.1016\/j.ejim.2011.04.009_bb0565","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/archsurg.2007.46","article-title":"Predictors of mortality after colectomy for fulminant Clostridium difficile colitis","volume":"143","author":"Byrn","year":"2008","journal-title":"Arch Surg"},{"key":"10.1016\/j.ejim.2011.04.009_bb0570","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.amjsurg.2007.11.017","article-title":"Outcome of colectomy for Clostridium difficile colitis: a plea for early surgical management","volume":"196","author":"Hall","year":"2008","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejim.2011.04.009_bb0575","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1007\/s10350-004-0672-2","article-title":"Outcome after colectomy for Clostridium difficile colitis","volume":"47","author":"Longo","year":"2004","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejim.2011.04.009_bb0580","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.amjsurg.2008.11.001","article-title":"Early colectomy may be associated with improved survival in fulminant Clostridium difficile colitis: an 8-year experience","volume":"197","author":"Seder","year":"2009","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejim.2011.04.009_bb0585","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/000313481007600421","article-title":"Colectomy for fulminant Clostridium difficile colitis: predictors of mortality","volume":"76","author":"Perera","year":"2010","journal-title":"Am Surg"},{"key":"10.1016\/j.ejim.2011.04.009_bb0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2009.07.040","article-title":"Surgical aspects of fulminant Clostridium difficile Colitis","author":"Butala","year":"2010","journal-title":"Am J Surg"},{"key":"10.1016\/j.ejim.2011.04.009_bb0595","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1053\/j.gastro.2008.01.004","article-title":"Impact of hospital volume on postoperative morbidity and mortality following a colectomy for ulcerative colitis","volume":"134","author":"Kaplan","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejim.2011.04.009_bb0600","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s11605-009-1093-2","article-title":"C. difficile colitis\u2014predictors of fatal outcome","volume":"14","author":"Dudukgian","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.ejim.2011.04.009_bb0605","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1463-1318.2005.00876.x","article-title":"The outcome of surgery in fulminant Clostridium difficile colitis","volume":"8","author":"Koss","year":"2006","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.ejim.2011.04.009_bb0610","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/000313481007600301","article-title":"Clostridium difficile and the surgeon","volume":"76","author":"Stanley","year":"2010","journal-title":"Am Surg"},{"key":"10.1016\/j.ejim.2011.04.009_bb0615","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/sur.2010.026","article-title":"Avoiding colectomy during surgical management of fulminant clostridium difficile colitis","volume":"11","author":"Olivas","year":"2010","journal-title":"Surg Infect"},{"key":"10.1016\/j.ejim.2011.04.009_bb0620","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/s11605-009-0819-5","article-title":"Long-term follow-up of patients with fulminant Clostridium difficile colitis","volume":"13","author":"Miller","year":"2009","journal-title":"J Gastrointest Surg"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511000884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620511000884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,24]],"date-time":"2021-11-24T21:12:39Z","timestamp":1637788359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620511000884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":124,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0953620511000884"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2011.04.009","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}